Cholangiocarcinoma is the most frequent biliary malignancy. It is difficult to diagnose owing
to its anatomic location, growth patterns and lack of definite diagnostic criteria. Currently …

These recommendations provide a data-supported approach to the diagnosis, staging and
treatment of patients diagnosed with hepatocellular carcinoma (HCC). They are based on …

The NCCN Guidelines for Hepatobiliary Cancers focus on the screening, diagnosis, staging,
treatment, and management of hepatocellular carcinoma (HCC), gallbladder cancer, and …

Background & Aims Obesity defined by body mass index (BMI) significantly increases the
risk of hepatocellular carcinoma (HCC). In contrast, not only obesity but also underweight is …

Hepatocellular carcinoma (HCC) is a neoplasm the incidence of which is increasing
worldwide, but striking geographical differences are observed for both risk factors and …

The diagnosis and treatment of hepatocellular carcinoma (HCC) have witnessed major
changes over the past decade. Until the early 1990s, HCC was a relatively rare malignancy …

Background & Aims: The surgical indications for multiple hepatocellular carcinomas (HCCs)
and for HCC with portal hypertension (PHT) remain controversial. Methods: We reviewed …

BACKGROUND: Despite significant advances in the treatment of intrahepatic lesions, the
prognosis for patients with hepatocellular carcinoma (HCC) who have extrahepatic …

Hepatobiliary cancers are highly lethal. In 2008, approximately 21,370 persons in the United
States were estimated to be diagnosed with liver or intrahepatic bile duct cancer and 9520 …

2.0 BACKGROUND Mortality rates from intrahepatic cholangiocarcinoma have risen steeply
and steadily over the past 30 years and since the mid 1990s more deaths have been coded …